How to Buy Perkinelmer Stock

Perkinelmer Inc

Perkinelmer is a diagnostic & research company located in Massachusetts, United States, which is part of the Healthcare sector, and is traded under the ticker PKI on the NYSE exchange.

Perkinelmer stock last closed at $137.90, down 2.72% from the previous day, and has decreased 24.43% in one year. It has underperformed other stocks in the Diagnostics & Research industry by 0.12 percentage points. Perkinelmer stock is currently +21.54% from its 52-week low of $113.46, and -27.63% from its 52-week high of $190.56.

As of Feb 6, 2023, there are 126.32M PKI shares outstanding. The market capitalization of PKI is $17.42B. In the last 24 hours, 528,362 PKI shares were traded.

How to Buy Perkinelmer Stock

Wondering how to invest in Perkinelmer stock? Here's how.
  1. Decide where to buy Perkinelmer stock: You need to pick an online brokerage, but don't worry - we've researched dozens of online stock brokerages and apps to help you decide where to buy Perkinelmer stock.
  2. Sign up for a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
  3. Fund your investment account: Select your method of payment and add your details.
  4. Analyze Perkinelmer stock: The Perkinelmer ticker symbol is PKI. Is Perkinelmer stock a good investment? Should you buy shares of PKI? How do PKI's underlying business fundamentals look? Do top analysts think Perkinelmer is a good buy? Why has PKI's stock price moved recently? (Hint: Our stock research tools can help you figure out if PKI is a good stock to buy).
  5. Place your PKI buy order: Decide if you will purchase PKI shares at the current market price or use a limit order to purchase PKI stock at a particular price.
  6. Monitor your investment in PKI: Create a watchlist to important notifications about your position in Perkinelmer shares.

Step 1: Decide where to buy Perkinelmer stock

You need an online brokerage account to access the NYSE market and buy PKI stock.

A brokerage account enables you to buy and sell a variety of investments, such as stocks, bonds, mutual funds, and ETFs.

Our preferred brokerage: eToro

Based on our experience, eToro is the best stock brokerage. eToro gives you:

  • You can invest in stocks with 0% commissions: Invest without paying trading commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
  • Access to world financial markets: From Tech to Utilities, New York to London — you can fill your portfolio with stocks from the world's leading exchanges.
  • Social investing: eToro boasts a community of more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of other investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other assets: Such as ETFs and cryptocurrencies.

Get $10 towards your share purchase by signing up for an account with eToro today.

Open eToro Account

Step 2: Sign up for a brokerage account

Now that you've selected the best brokerage, it's time to fill out some personal details so you are able to buy PKI stock today.

How to Open a New Brokerage Account on eToro

  1. Click here to get started.
  2. Input your personal info to open your new brokerage account.
  1. Send your details by hitting the "Create Account" button.
Get started with eToro today

Step 3: Fund your investment account

Now that you have finished signing up on the best stock market app, you need to deposit funds:

Check out this video walkthrough for more details transferring funds into your new investment account.

Get started with eToro today

Step 4: Analyze Perkinelmer stock

Once you have selected the best place to buy Perkinelmer stock, it's critical to evaluate their stock before you buy, so you truly wrap your head around the risk and opportunity.

Perkinelmer stock at a glance

PKI Price
1w %
1y %
5y %
Fore. Rev. Growth
Fore. Earn. Growth
Market Cap
Next Earnings
Feb 14, 2023
Next Dividend
Feb 10, 2023

Fundamentals of PKI

WallStreetZen was built to help average investors perform more in-depth fundamental analysis in minutes instead of hours.

You can view all of the due diligence checks on PKI's stock page.

What is the fair value of PKI stock?

Analysts use a variety of different financial metrics, analyses, models, and charts to gauge PKI's true value.

Using relative valuations ratios:

  • PKI may be undervalued based on its P/E ratio of 27.86x, relative to Diagnostics & Research industry P/E ratio of 37.26x
  • PKI could be undervalued based on its P/B ratio of 2.47x, relative to Diagnostics & Research industry P/B ratio of 4.46x
  • PKI could be overvalued based on its PEG ratio of 1.05x

You can do more valuation analysis on PKI's stock here.

A look at PKI Cashflows and Balance Sheet

Positive Health Checks:

  • PKI earnings of $951.68M is not sufficient to cover its interest payments.
  • There are more short-term assets than short-term liabilities on the PKI balance sheet.

Negative Health Checks:

  • PKI profit margin has gone down from 23.8% to 13.8% in the past year.
  • PKI has a relatively high debt to equity ratio of 0.96.
  • Total PKI debt is higher than 5 years ago, relative to shareholder equity.
  • There are more long-term liabilities than short-term assets on the PKI balance sheet.
  • PKI's operating cash flow of $876.24M allows it to safely service it's debt of $4.54B.

Is Perkinelmer stock a Buy, Hold, or Sell, according to analysts?

Out of 11 Wall Street analysts who research PKI, the consensus analyst rating on Perkinelmer is a Buy

It's important to keep in mind that analyst ratings are not stock recommendations, nor are they financial advice.

Latest PKI Analyst Upgrades/Downgrades

Luke Sergott, a bottom 2% analyst from Barclays maintains PKI with a hold rating and lowers their PKI price target from $145.00 to $140.00, on Jan 24, 2023.

Paul Knight, a top 9% analyst from KeyBanc upgrades PKI to a strong buy rating and announces their PKI price target of $170.00, on Dec 19, 2022.

Patrick B Donnelly, a top 5% analyst from Citigroup upgrades PKI to a strong buy rating and announces their PKI price target of $170.00, on Dec 12, 2022.

Max Masucci, a bottom 4% analyst from Cowen & Co. upgrades PKI to a buy rating and lowers their PKI price target from $192.00 to $164.00, on Dec 6, 2022.

Dan Leonard, a top 7% analyst from Credit Suisse maintains PKI with a hold rating and lowers their PKI price target from $175.00 to $160.00, on Nov 14, 2022.

You can dive deeper into what analysts are saying on the Perkinelmer stock forecast page.

Metrics for Advanced PKI Traders

MACD Signal
MACD Histogram
Stochastic %K
Stochastic %D
StochRSI %K
StochRSI %D

PKI Growth Numbers

Last year, PKI earnings were $631.71M. During the last 5 year, PKI's earnings have increased by 6.4% per year. This was slower than the Diagnostics & Research industry average of 22.2%.

Last year, PKI revenue was $4.57B. During the past five year, PKI's revenue has increased by 15.91% per year. This was slower than the Diagnostics & Research industry average of 16.39%.

Learn more about PKI's earnings and revenue performance here.

Who is buying/selling PKI?

Over the past 12 months, insiders at PKI have sold more shares than they have bought.

Joel S. Goldberg, Senior Vice President Administration General Counsel and Secretary of PKI, was the latest PKI insider to sell. They sold $187,333.12 worth of PKI shares on Jan 30, 2023.

Research more about who owns PKI shares here.

Does PKI stock generate passive income?

Perkinelmer pays a dividend of 0.2%, compared to the Diagnostics & Research industry's average dividend yield of 1.7%. If you owned $1,000 of PKI stock, you would have received $2.03 in the past 12 months.

Perkinelmer dividend payments have not consistently grown over the past decade but have remained stable.

Get more data about Perkinelmer dividend yield and history here.

What others are saying about PKI

One of the reasons eToro is our highest-rated brokerage is because of its social trading community.

Click below to learn what other traders have to say.

Step 5: Place your PKI buy order

You have two main options:

  • Market order: A market order is an order to buy or sell a stock at the best possible price.
    Market orders are generally fine.
  • Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
    If you want to be sure you're buying or selling at a particular dollar amount, place a limit order.

Press the Open Trade button and your broker will execute your order.

If you need additional assistance buying stocks on eToro, click the helpful video below:

Open eToro Account

Step 6: Monitor your investment in PKI

Now that you own some PKI shares, you'll want to stay up-to-date on your investment.

Put PKI on a watchlist to keep track of your PKI stock.

PKI Feed

How to Buy Stock in Perkinelmer

To summarize, here are the 6 steps you need to take to buy Perkinelmer stock right now:

  1. Decide where to buy Perkinelmer stock
  2. Sign up for a brokerage account
  3. Fund your investment account
  4. Analyze Perkinelmer stock
  5. Place your PKI buy order
  6. Monitor your investment in PKI

If you are looking for a place to buy stocks, eToro is our recommended venue.

Get Started with eToro Today

If you would like to monitor your investment in Perkinelmer, create a watchlist on WallStreetZen today.

$137.90-3.85 (-2.72%)
Updated Feb 6, 2023
Open eToro Account
$137.90-3.85 (-2.72%)
Updated Feb 6, 2023
Open eToro Account


How much does it cost to buy one Perkinelmer share?

As of Feb 6, 2023, it costs $137.90 to buy one share of Perkinelmer stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.073 shares of PKI.

Get Started with eToro Today

Is now a good time to buy Perkinelmer stock?

According to 11 Wall Street analysts who monitor Perkinelmer, their consensus recommendation is to buy Perkinelmer stock.

What is the best way to buy Perkinelmer stock?

One way to place an order for Perkinelmer stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.